City

Rotterdam (1)

Condition

Neuroendocrine Tumors (2)

Peptide Receptor Radionuclide Therapy (2)

Quality of Life (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Erasmus Medical Center (1)

Uppsala University (1)

Collaborator

Intervention

olaparib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

peptide receptor radionuclide therapy

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)

Recruiting

Neuroendocrine Tumors
Peptide Receptor Radionuclide Therapy

olaparib

Rotterdam, South Holland, Netherlands

Erasmus MC

May 19, 2023

HRQoL During PRRT in Patients With NETs

Completed

Neuroendocrine Tumors
+2 more

(no location specified)

Jun 16, 2022